Eli Lilly has outstanding growth prospects thanks to its leadership in its core therapeutic area. AbbVie’s immunosuppressant portfolio helps it to produce steady revenue and profits.
Source: https://www.fool.com/investing/2026/01/19/best-healthcare-st…
Greg Abel took over for Warren Buffett at the start of 2026, managing the bulk of Berkshire’s portfolio. Abel said there are nine stocks where Berkshire will exhibit limited trading activity.
These three stocks all offer must-have products, regardless of macroeconomic conditions. Public safety services, pest control solutions, and low prices at the pump may not seem exciting.
Lumentum and Coherent have market caps of more than $40 billion, well above the threshold for S&P 500 inclusion.
